Osteofibrous Dysplasia (Kempson-Campanacci's Disease): Long Term Follow-up Study on Natural History, Results of Treatment and Relationship With Adamantinoma

Osteofibrous Dysplasia (Kempson-Campanacci's Disease)

Sponsors

Lead sponsor: Istituto Ortopedico Rizzoli

Source Istituto Ortopedico Rizzoli
Brief Summary

The aim of the present study is to obtain long term follow-up in patients with osteofibrous dysplasia, to assess natural history of the disease, late results of treatment and in particular the potential and risk of progression to adamantinoma.

Overall Status Recruiting
Start Date August 8, 2019
Completion Date April 30, 2020
Primary Completion Date November 30, 2019
Study Type Observational
Primary Outcome
Measure Time Frame
Osteofibrous Dysplasia (Kempson-Campanacci's disease): Long Term Follow-up Study on Natural History, Results of Treatment and Relationship with Adamantinoma BASELINE
Enrollment 55
Condition
Intervention

Intervention type: Behavioral

Intervention name: study of osteofibrous dysplasia features

Description: obtain long term follow-up in patients with osteofibrous dysplasia, to assess natural history of the disease, late results of treatment and in particular the potential and risk of progression to adamantinoma.

Eligibility

Sampling method: Probability Sample

Criteria:

Inclusion Criteria:

- Male and female patients treated at Rizzoli Institute from 01 Jan 1943 to 31 Dic 2011

- Diagnosis of osteofibrous dysplasia pathologically confirmed

- Written informed consent prior to any study-specific analysis and/or data collection

Exclusion Criteria:

- Patients with histological diagnosis different from osteofibrous dysplasia

Gender: All

Minimum age: N/A

Maximum age: N/A

Healthy volunteers: No

Overall Contact

Last name: ALBERTO RIGHI, MD PhD

Phone: +39-051-636

Phone ext: 6665

Email: [email protected]

Location
facility status contact
Dept. of Pathology of IRCCS Istituto Ortopedico Rizzoli Recruiting Alberto Righi, MD +39051.63.66 665 [email protected]
Location Countries

Italy

Verification Date

January 2020

Responsible Party

Responsible party type: Principal Investigator

Investigator affiliation: Istituto Ortopedico Rizzoli

Investigator full name: Alberto Righi

Investigator title: Principal Investigator

Has Expanded Access No
Condition Browse
Acronym DOFOL
Study Design Info

Observational model: Case-Only

Time perspective: Retrospective

Source: ClinicalTrials.gov